Multiple Sclerosis: Looking beyond Autoimmunity

Thomas L. Falsity and failure. In: Late Night Thoughts on Listening to Mahler's Ninth Symphony. New York: Penguin Books, 1995: 113.

Behan P.O. , Chaudhuri A. , Roep B.O. The pathogenesis of multiple sclerosis revisited. J R Coll Physicians Edinb 2002; 32: 244–65

Weiner H.L. Multiple sclerosis is an inflammatory, T-cell mediated autoimmune disease. Arch Neurol 2004; 61: 1613–15

Chaudhuri A. , Behan P.O. Multiple sclerosis is not an autoimmune disease. Arch Neurol 2004; 61: 1610–12

Ebers G.C. , Sandovnick A.D. , Dyment D.A. , Yee J.M.L. , Willer C.J. , Risch N. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 2004; 363: 1773–4

Lumsden C. The neuropathology of multiple sclerosis. In: Bruyn G.W. , Vinken P. , eds. Handbook of Clinical Neurology. Amsterdam: Elsevier, 1970: 217–309

Dalton C.M. , Chard C.T. , Davies G.R. . Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101–7

Adams R.D. A comparison of the morphology of the human demyelinative diseases and experimental ‘allergic’ encephalomyelitis. In: Kies M.W. , Alvord EC Jr , eds. “Allergic” Encephalomyelitis. Washington: Charles C Thomas, 1959: 183–209

Behan P.O. , Geshwind N. , Lamarche J.B. . Delayed hypersensitivity to encephalitogenic protein in disseminated encephalitis. Lancet 1968; ii: 1009–12

Behan P.O. , Kies M.W. , Lisak R.P. . Immunologic mechanisms in experimental encephalomyelitis in non-human primates. Arch Neurol 1973; 29: 4–9

Ingelse M. , Salvi F. , Iannucci G. . Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. Am J Neuroradiol 2002; 23: 267–72

Graham D.I. , Behan P.O. , More I.A.R. Brain damage complicating septic shock. Acute haemorrhagic leukoencephalitis as a complication of generalised Shwartzman reaction. J Neurol Neurosurgery Psychiatry 1979; 42: 19–28

Lennon V.A. , Wingerchuck D.M. , Kryzer T.J. . A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106–12

Chaudhuri A. , Behan P.O. Treatment of multiple sclerosis beyond the NICE guideline. Quart J Med 2005; 98: 373–8

Chaudhuri A. Beta interferon, progressive multiple sclerosis and brain atrophy. Lancet Neurol 2005; 4: 208–9

Kalkers N.F. , Ameziane N. , Boost J.C.J. , Minnebo A. , Polman C.H. , Barkhof F. Longitudinal brain volume measurement in multiple sclerosis. Rate of brain atrophy is independent of the disease subtype. Arch Neurol 2002; 59: 1572–6

Lucchinetti C. , Bruck W. , Parisi J. , Scheithauer B. , Rodriguez M. , Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for pathogenesis of demyelination. Ann Neurol 2000; 47: 707–17

Hernan M.A. , Zhang S.M. , Lipworth L. , Olek M.J. , Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology 2001; 12: 301–6

Macsween K.F. , Crawford D.H. Epstein–Barr virus—recent advances. Lancet Infect Dis 2003; 3: 131–40

Hernan M.A. , Olek M.J. , Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001; 154: 69–74

Riise T. , Nortvedt M. , Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 2003; 61: 1122–4

Chaudhuri A. Why we should offer routine supplementation of vitamin D in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses 2005; 64: 608–18

Munger K.L. , Zhang S.M. , O'Reilly E. . Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 13: 62: 60–5

Acheson E.D. , Bachrach C.A. , Wright F.M. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiatry Scand 1960; 147(suppl): 132–47

Landtblom A-M , Flodin U. , Soderfeldt B. , Wolfson C. , Axelson O. Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology 1996; 7: 429–33

Riise T. , Moen B.E. , Kryvik K.R. Organic solvents and the risk of multiple sclerosis. Epidemiology 2002; 13: 718–20

Shultz C.W. Coenzyme Q10 in neurodegenerative diseases. Curr Med Chem 2003; 19: 1917–21

Calon F. , Lim G.P. , Yang F. . Docosahexanoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004; 43: 633–34

Chen M. , Ona V.O. , Li M. . Minocycline inhibits caspase-3 expression and delays mortality in a transgenic mouse model of Huntington's disease. Nature Med 2000; 6: 797–801

Baker D. , Pryce G. , Giovannoni G. . The therapeutic potential of cannabis. Lancet Neurol 2003; 2: 291–8